debate: which is the optimal approach for cll? - br
Published 11 years ago • 77 plays • Length 12:08Download video MP4
Download video MP3
Similar videos
-
14:21
debate: which is the optimal approach for cll? - fcr
-
9:38
debate: which initial therapy for younger fit patients is best? - krd and vrd
-
15:23
debate: optimal approach for the management of cll patients with del(17p) - ibrutinib
-
14:29
debate: what is the best approach for relapsed t cell lymphoma? - allosct
-
15:45
debate: optimal sequencing of multimodality treatment in rectal cancer - medical oncologist's pov
-
14:13
debate: optimal sequencing of multimodality treatment in rectal cancer - radiation oncologist's pov
-
11:58
debate: do molecular characteristics play a role in selecting patients for metastasectomy? - no
-
14:03
debate: best approach for multiple relapsed cll after chemoimmunotherapy - asct
-
1:37
when should i seek a second opinion for my lymphoma diagnosis? | lymphoma faqs
-
1:32:16
an answer to cancer? using the immune system to fight cancer -- longwood seminar
-
19:23
lymphoma explained clearly - hodgkins & non-hodgkin's pathophysiology
-
59:57
11/22/2024 - cancer survivorship: the lymphoma paradigm
-
12:40
debate: a case of stage iv follicular lymphoma - r-chop or b-r
-
12:04
debate: best second-line approach to induce lymphoma remission prior to sct? - chemotherapy
-
19:14
debate: best approach for multiple relapsed cll after chemoimmunotherapy - other novel agents
-
14:00
debate: optimal treatment of localized hcc? - resection or transplant
-
15:14
debate: ngs testing for all patients with gi cancers? - yes
-
14:13
debate: do we have enough data to eliminate chemotherapy from initial treatment for cll? - yes
-
15:59
debate: to maintain or not to maintain? immunomodulators vs. pi - no
-
13:34
debate: what is the treatment choice for waldenstrom macroglobulinemia? - bendamustine
-
10:45
debate: what is the optimal chemotherapy for stage iii nsclc? - cisplatin/etoposide is the standard
-
14:48
debate: best frontline regimen for a cll patient aged 60 who requires therapy - ibrutinib